Zhi Jun Zhang

Shanghai Zhimeng Biopharma, Inc. is a clinical-stage biopharmaceutical company located in the resource-rich Zhangjiang High Tech Park of Shanghai, China. The Chinese company is committed to developing innovative drugs for the treatment of chronic hepatitis B (CHB) and severe neurological diseases with significant unmet medical needs. Founded in 2017, Zhimeng Pharmaceutical Technology Co., Ltd. is a biotechnology company dedicated to the development of drugs for the treatment of CHB and related liver diseases. The company was founded by Huan Ming Chen, Zhi Jun Zhang, and Bo Liang, with Huan Ming Chen serving as the CEO since 2015.